Aster DM Quality Care Limited
NSE: ASTERDMINE914M01019·HealthcareSmallcap 250·www.asterqualitycare.com ↗·Mcap ₹66,295 Cr·Listed 2018
₹759.40▼ ₹9.25  (−1.20%)
52W: ₹519 – ₹891 · Vol: 12.5L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q1 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q4 FY18Q3 FY18Q2 FY18Q1 FY18
Revenue from operations1,3111,1821,1861,1971,0781,0001,0501,0861,0029743,7113,3173,2153,2623,1922,8162,6622,7282,6502,5042,3722,3912,2592,2681,7612,3012,3222,0872,0292,2011,7842,1501,8371,775
Other income3736.22828.333.231.33335.248.74.188.69.2148.518.437.32211.59.1829.85.77.96.526.63.94.13.37.59.15.816.217.3
Total expenses1,1471,0471,0741,0449659059549609289023,4773,2683,1443,0713,0282,7642,6142,4982,4802,3792,3102,2992,1502,2241,8532,1812,1482,0792,0191,9841,6232,0221,8271,765
EBITDA264233211250207192189220164159564377388506449319292463397343281321328271143404385245224350263263125124
EBITDA margin20.2%19.7%17.8%20.9%19.2%19.2%18.0%20.2%16.3%16.4%15.2%11.4%12.1%15.5%14.1%11.3%11.0%17.0%15.0%13.7%11.8%13.4%14.5%12.0%8.1%17.6%16.6%11.7%11.0%15.9%14.7%12.2%6.8%7.0%
Finance costs31.23031.530.830.832.430.831.529.229.998.610298.99687.277.268.862.266.961.466.576.762.174.680.311271.588.487.755.446.656.439.540.1
Depreciation69.367.267.766.163.26462.262.360.458.42322272172191981891751701611561531531571531551711401491267855.778.975.873.8
Profit before tax86.517211218114210110516112375.22422.180.620517270.885.625218113469.512211451.5−85.714615911.613.222521513424.827.4
Tax48.89.844.445.542.9537.552.93930.624.210.253.423.214.416.55.54.213.17.610.95.37.810.33.9−0.18.252.24.410.316.710.211.7
Net profit29.315458.712193.685.564.41065,152−2.2209−15.319.918315954.179.824616812859.611710742.3−88.61461516.910.122020511313.920.4
Net margin2.2%13.0%4.9%10.1%8.7%8.6%6.1%9.7%514.3%-0.2%5.6%-0.5%0.6%5.6%5.0%1.9%3.0%9.0%6.3%5.1%2.5%4.9%4.8%1.9%-5.0%6.4%6.5%0.3%0.5%10.0%11.5%5.3%0.8%1.1%
EPS (₹)0.312.721.022.131.671.591.141.941.490.663.60-0.620.103.432.800.931.384.552.982.150.892.121.860.66-1.672.612.780.060.064.164.072.000.220.25
Net profit YoY−68.7%+79.5%−8.9%+14.7%−98.2%+4041.9%−69.2%+789.9%+25855.7%−101.2%+31.6%−128.3%−75.1%−25.7%−5.5%−57.6%+33.8%+110.4%+56.5%+202.1%+167.3%−20.2%−29.0%+515.0%−981.5%−33.4%–––+7.1%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19FY18
Revenue from operations4,6434,1383,69911,93310,2538,6088,7397,9636,721
Other income12614824.978.350.75037.934.645.4
Total expenses4,1293,7473,45111,4779,6688,4578,4277,5856,591
EBITDA9017655781,5651,4831,0631,258863613
EBITDA margin19.4%18.5%15.6%13.1%14.5%12.3%14.4%10.8%9.1%
Finance costs123124110329257294360179185
Depreciation264249220780641618586306298
Profit before tax607490273534636202330411305
Tax14313456.559.635.827.215.442.926.1
Net profit4275,408212475601178315367282
Net margin9.2%130.7%5.7%4.0%5.9%2.1%3.6%4.6%4.2%
EPS (₹)7.536.163.608.5510.582.975.516.635.75
Net profit YoY−92.1%+2456.2%−55.5%−20.9%+238.0%−43.5%−14.3%+30.4%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow6564251581,8341,313
Investing cash flow−2886,015−885−972−570
Financing cash flow−304−6,3581,053−817−685
Capital expenditure469346797717483
Free cash flow (CFO − capex)18779−6391,117830

Net profit trend

annual, ₹ crore
FY21
₹178
FY22
₹601+238%
FY23
₹475−21%
FY24
₹212−56%
FY25
₹5,408+2456%
FY26
₹427−92%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated5 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone5 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited30 Apr 2026PDF on NSE XBRL
Q4 FY26Standalone · audited30 Apr 2026PDF on NSE XBRL
Q3 FY26Consolidated30 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone30 Jan 2026PDF on NSE XBRL
Q2 FY26Consolidated6 Nov 2025 PDF XBRL
Q2 FY26Standalone6 Nov 2025 PDF XBRL
Q1 FY26Consolidated30 Jul 2025 PDF XBRL
Q1 FY26Standalone30 Jul 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 53.1×108.4×
P/B5Y avg 5.35×8.60×
ROEFY26, on average equity10.7%
Net margin9.2%
Debt / equity0.15×
Revenue CAGR (3Y)-27.0%
Profit CAGR (3Y)-3.5%
EPS (TTM)₹7.00
Market cap₹39,347 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
8.60×
vs 8-point avg 5.35× (+61%)
2.80× low5.35× avg8.60× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹8,112 Cr+23%
Net worth₹4,576 Cr+33%
Total borrowings₹701 Cr+9%
Cash & bank balances₹228 Cr+39%
Investments₹973 Cr+6969%
Inventories₹91 Cr−1%
Trade receivables₹307 Cr+19%
Trade payables₹482 Cr+13%
Change vs the same date a year earlier.
Revenue mix FY26
Hospitals & Clinics94.2%result ₹780 Cr
Labs3.2%result ₹14.8 Cr
Wholesale Pharmacies2.3%result ₹0.8 Cr
Others0.3%result ₹−17 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 13 Jul 2026
%Jul 26Jun 26Mar 26Dec 25Sept 25Jun 25Apr 25Mar 25Dec 24Sept 24Jun 24Mar 24
Promoter53.7240.3940.3940.3940.3940.3940.3841.8941.8841.8841.8841.88
FII10.3110.5317.1818.4618.7219.6423.6221.6622.6223.8527.0833.48
DII16.4827.6527.5726.1226.3225.2824.6324.5922.9120.9116.3513.70
of which MF15.9326.7026.4524.6024.8923.87––––––
Retail4.453.703.934.073.863.944.124.375.045.946.973.09
Other public15.0417.7310.7010.7310.4810.507.007.237.277.127.407.50
1,33,338 shareholders · NSE shareholding pattern filings.